Inspire Common Stock Shares Outstanding vs Other Stockholder Equity Analysis
INSP Stock | USD 158.79 4.42 2.86% |
Inspire Medical financial indicator trend analysis is infinitely more than just investigating Inspire Medical Systems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inspire Medical Systems is a good investment. Please check the relationship between Inspire Medical Common Stock Shares Outstanding and its Other Stockholder Equity accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
Common Stock Shares Outstanding vs Other Stockholder Equity
Common Stock Shares Outstanding vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inspire Medical Systems Common Stock Shares Outstanding account and Other Stockholder Equity. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Inspire Medical's Common Stock Shares Outstanding and Other Stockholder Equity is 0.94. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Inspire Medical Systems, assuming nothing else is changed. The correlation between historical values of Inspire Medical's Common Stock Shares Outstanding and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Inspire Medical Systems are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Common Stock Shares Outstanding i.e., Inspire Medical's Common Stock Shares Outstanding and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.94 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Other Stockholder Equity
Most indicators from Inspire Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inspire Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. At this time, Inspire Medical's Selling General Administrative is relatively stable compared to the past year. As of 06/02/2024, Tax Provision is likely to grow to about 939.8 K, while Enterprise Value Over EBITDA is likely to drop (151.23).
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 8K | 5.0M | 2.8M | 1.7M | Interest Income | 125K | 5.1M | 18.1M | 19.0M |
Inspire Medical fundamental ratios Correlations
Click cells to compare fundamentals
Inspire Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Inspire Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 23.8M | 26.1M | 27.3M | 28.1M | 29.3M | 22.9M | |
Total Assets | 181.3M | 281.2M | 295.1M | 564.9M | 676.8M | 710.7M | |
Short Long Term Debt Total | 24.5M | 30.6M | 33.8M | 8.9M | 24.8M | 24.7M | |
Other Current Liab | 12.4M | 13.5M | 20.5M | 33.0M | 39.3M | 41.2M | |
Total Current Liabilities | 16.9M | 20.7M | 41.3M | 61.2M | 78.1M | 82.0M | |
Total Stockholder Equity | 139.8M | 229.7M | 229.0M | 496.0M | 572.5M | 601.1M | |
Net Tangible Assets | 139.8M | 229.7M | 229.0M | 496.0M | 570.4M | 598.9M | |
Property Plant And Equipment Net | 4.0M | 11.1M | 16.4M | 24.1M | 62.7M | 65.8M | |
Net Debt | 1.7M | (159.9M) | (180.7M) | (432.7M) | (160.7M) | (168.7M) | |
Retained Earnings | (180.2M) | (237.3M) | (279.4M) | (324.3M) | (345.4M) | (362.7M) | |
Accounts Payable | 4.5M | 7.2M | 11.7M | 26.8M | 38.8M | 40.8M | |
Cash | 22.9M | 190.5M | 214.5M | 441.6M | 185.5M | 160.6M | |
Non Current Assets Total | 10.6M | 11.3M | 26.5M | 34.8M | 83.1M | 87.2M | |
Non Currrent Assets Other | 802K | 381K | 204K | 215K | 11.3M | 11.8M | |
Long Term Debt | 24.9M | 24.5M | 24.7M | 15.8M | 18.2M | 21.8M | |
Cash And Short Term Investments | 149.5M | 234.4M | 214.5M | 451.4M | 460.4M | 236.7M | |
Net Receivables | 13.1M | 25.1M | 34.2M | 61.2M | 89.9M | 94.4M | |
Common Stock Total Equity | 23K | 24K | 27K | 29K | 33.4K | 22.6K | |
Short Term Investments | 90.9M | 126.6M | 43.8M | 9.8M | 274.8M | 288.6M | |
Long Term Debt Total | 24.9M | 24.5M | 24.7M | 15.8M | 18.2M | 21.8M | |
Liabilities And Stockholders Equity | 181.3M | 281.2M | 295.1M | 564.9M | 676.8M | 710.7M | |
Non Current Liabilities Total | 24.6M | 30.7M | 24.7M | 7.7M | 26.2M | 23.1M | |
Capital Surpluse | 319.9M | 467.0M | 508.5M | 820.3M | 943.4M | 990.6M | |
Inventory | 5.8M | 8.5M | 17.2M | 11.9M | 33.9M | 35.6M | |
Other Current Assets | 2.2M | 2.0M | 2.7M | 5.5M | 9.6M | 10.1M | |
Other Stockholder Equity | 319.9M | 467.0M | 508.5M | 820.3M | 917.1M | 478.1M | |
Total Liab | 41.4M | 51.4M | 66.0M | 68.9M | 104.3M | 56.6M | |
Property Plant And Equipment Gross | 4.0M | 11.1M | 16.4M | 24.1M | 69.9M | 73.4M | |
Total Current Assets | 170.6M | 269.9M | 268.5M | 530.0M | 593.7M | 623.4M | |
Accumulated Other Comprehensive Income | 102K | 29K | (55K) | (86K) | 800K | 840K | |
Common Stock | 23K | 24K | 27K | 29K | 30K | 23.9K | |
Property Plant Equipment | 4.0M | 5.3M | 16.4M | 17.2M | 19.8M | 20.8M | |
Net Invested Capital | 164.4M | 254.5M | 254.0M | 496.0M | 572.5M | 306.2M | |
Net Working Capital | 153.8M | 249.1M | 227.2M | 468.8M | 515.6M | 286.0M | |
Retained Earnings Total Equity | (180.2M) | (237.3M) | (279.4M) | (324.3M) | (291.8M) | (306.4M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Inspire Stock analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Inspire Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inspire Medical. If investors know Inspire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inspire Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.682 | Earnings Share (0.52) | Revenue Per Share 22.454 | Quarterly Revenue Growth 0.282 | Return On Assets (0.04) |
The market value of Inspire Medical Systems is measured differently than its book value, which is the value of Inspire that is recorded on the company's balance sheet. Investors also form their own opinion of Inspire Medical's value that differs from its market value or its book value, called intrinsic value, which is Inspire Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inspire Medical's market value can be influenced by many factors that don't directly affect Inspire Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inspire Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspire Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inspire Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.